Bottom line
FHCLX vs HIAHX: the short answer
FHCLX (Health Care Portfolio) and HIAHX (Hartford Healthcare Hls Fund) are both mutual funds.
FHCLX is cheaper at 0.91% vs 0.94% — a difference of $3.00 a year per $10,000 invested.
Over five years, FHCLX returned +4.0% a year vs +3.5% for HIAHX (reporting dates differ).
Updated Nov 19, 2026
FHCLX vs HIAHX side by side
| FHCLX | HIAHX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.91% | 0.94% |
| Annual cost per $10k | $91 | $94 |
| 10-yr cost on $10k (prospectus) | $1,630 | $1,155 |
| Max front load | — | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +14.4% | +16.1% |
| 5-yr return (annualized) | +4.0% | +3.5% |
| 10-yr return (annualized) | +9.0% | +7.9% |
| Best quarter | +22.2% | +21.0% |
| Worst quarter | −15.0% | −15.6% |
| Net assets (fund) | $5.8B | $112.4M |
| Number of holdings | 152 | 79 |
| Portfolio turnover | 69% | 5% |
| Returns as of | Feb 28, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FHCLX | HIAHX | Difference |
|---|---|---|---|
| 2025 | +14.4% | +16.1% | −1.7% |
| 2024 | +4.9% | +0.4% | +4.5% |
| 2023 | +4.1% | +4.1% | +0.0% |
| 2022 | −12.8% | −11.2% | −1.6% |
| 2021 | +11.5% | +10.0% | +1.5% |
| 2020 | +24.4% | +23.1% | +1.3% |
| 2019 | +31.5% | +34.0% | −2.5% |
| 2018 | +7.4% | −2.7% | +10.1% |
| 2017 | +24.0% | +22.3% | +1.8% |
| 2016 | −10.7% | −8.4% | −2.3% |
Source: Fund prospectus bar charts
Holdings overlap
12 of FHCLX's top 25 holdings also appear in HIAHX's top 25.
| Holding | FHCLX | HIAHX |
|---|---|---|
| ELI LILLY and CO | 8.03% | 12.47% |
| Danaher Corp | 6.89% | 2.65% |
| JOHNSON and JOHNSON | 4.91% | 6.63% |
| Thermo Fisher Scientific Inc | 4.33% | 1.64% |
| Unitedhealth Group Inc | 3.49% | 4.72% |
| Boston Scientific Corp | 2.17% | 1.19% |
| Abbvie Inc | 2.03% | 3.43% |
| MERCK and CO INC | 1.60% | 6.60% |
| Cvs Health Corp | 1.29% | 2.93% |
| Cencora Inc | 1.14% | 2.07% |
| Agilent Technologies Inc | 1.10% | 1.36% |
| Edwards Lifesciences Corp | 1.09% | 2.42% |
Source: SEC Form N-PORT
FHCLX top 10
- ELI LILLY and CO — 8.03%
- Danaher Corp — 6.89%
- JOHNSON and JOHNSON — 4.91%
- Thermo Fisher Scientific Inc — 4.33%
- Unitedhealth Group Inc — 3.49%
- Alnylam Pharmaceuticals Inc — 2.40%
- Gilead Sciences Inc — 2.21%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
HIAHX top 10
- Eli Lilly & Co — 12.47%
- Johnson & Johnson — 6.63%
- Merck & Co Inc — 6.60%
- UnitedHealth Group Inc — 4.72%
- AbbVie Inc — 3.43%
- Intuitive Surgical Inc — 2.99%
- Elevance Health Inc — 2.96%
- CVS Health Corp — 2.93%
- Vertex Pharmaceuticals Inc — 2.69%
- Danaher Corp — 2.65%
FAQ
What is the difference between FHCLX and HIAHX?
Which is cheaper, FHCLX or HIAHX?
Should I own both FHCLX and HIAHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.